AVONEX
Google image searchProduct monograph
Active ingredient
interferon beta-1a, 30 MCG/0.5 ML
DIN: 02269201
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: PREFILLED SYRINGE, PREFILLED AUTOINJECTOR
Schedule: Prescription / Schedule D
Company: BIOGEN CANADA INC
Date: 02-DEC-2005
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AB — Interferons (ATC, ATC/DDD)
- L03AB07 — INTERFERON BETA-1A (ATC/DDD)
Reference brand drug: Avonex, Rebif
